e-learning
resources
Barcelona 2013
Monday, 09.09.2013
The different modalities for current imaging and for future issues
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Shear Wave imaging (SVI): A potential tool for analyzing early fibrotic changes in the subpleural space
R. Kubale, J. Stroeder, R. Seidel, P. Lessenich, O. Uslu, A. Grgic, H. Wilkens (Homburg/Saar, Germany)
Source:
Annual Congress 2013 –The different modalities for current imaging and for future issues
Session:
The different modalities for current imaging and for future issues
Session type:
Oral Presentation
Number:
3022
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Kubale, J. Stroeder, R. Seidel, P. Lessenich, O. Uslu, A. Grgic, H. Wilkens (Homburg/Saar, Germany). Shear Wave imaging (SVI): A potential tool for analyzing early fibrotic changes in the subpleural space. Eur Respir J 2013; 42: Suppl. 57, 3022
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Imaging of complicated pneumonia: what is new?
Imaging of eosinophilic lung disease
Asbestosis
Related content which might interest you:
Interstitial pulmonary fibrosis model develpment and identification of early biomarkers by MALDI imaging
Source: International Congress 2015 – New insights into IIPs
Year: 2015
High resolution computed tomography (HRCT) can differentiate rapid from slow progressing Idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2014 – ILDs 2
Year: 2014
Quantitative lung T
1
mapping and oxygen enhanced MRI in IPF
Source: International Congress 2014 – The MRI modality becomes clinically mature: lung MRI
Year: 2014
Transient elastography detection of early liver fibrosis in idiopathic pulmonary fibrosis patients
Source: International Congress 2014 – ILDs 2
Year: 2014
Comet tail artifact: A transthoracic chest ultrasound sign useful in assessment of interstitial lung diseases
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view
Year: 2013
IPFdatabase
– A new tool for a correct application of idiopathic pulmonary fibrosis guidelines
Source: International Congress 2014 – ILDs 2
Year: 2014
LATE-BREAKING ABSTRACT: Molecular imaging with CXCR4-gallium-68-pentixafor PET correlates with GAP index and treatment effects in idiopathic pulmonary fibrosis
Source: International Congress 2016 – Mixed-up imaging of various chest diseases
Year: 2016
Combining immunostaining with micro-computed tomography to visualise the 3D distribution of mast cells in idiopathic pulmonary fibrosis
Source: International Congress 2016 – ILD pathogenesis
Year: 2016
Volumetric CT analysis of normal lung as a predictor of mortality in idiopathic pulmonary fibrosis
Source: International Congress 2016 – IPF: from pathogenesis to treatment II
Year: 2016
PET-CT with
18
F-FDG and
18
F-FBEM-labeled leukocytes for metabolic activity and leukocyte recruitment monitoring in a mouse model of pulmonary fibrosis
Source: International Congress 2014 – ILDs: pathogenesis and clinical features
Year: 2014
The myofibroblast in pulmonary fibrosis displays distinct functional characteristics, depending on its source of origin
Source: International Congress 2014 – ILDs 3
Year: 2014
Prognostic value of dual-time-point
18
F-FDG PET in fibrotic idiopathic interstitial pneumonia
Source: Annual Congress 2013 –Diffuse pulmonary fibrosis
Year: 2013
Discovery and validation of peripheral blood gene expression profiles predictive of poor outcome and disease progression in idiopathic pulmonary fibrosis
Source: International Congress 2014 – Pathogenetic mechanisms in pulmonary fibrosis
Year: 2014
3D-simulation in an integrated assessment of the dynamics in patients with disseminated pulmonary lesions (DPL)
Source: Annual Congress 2013 –Diffuse parenchymal lung disease I
Year: 2013
Oxygen-enhanced MR (OE-MR): Correlation to CT Brody score in cystic fibrosis patients
Source: International Congress 2016 – Cystic fibrosis: monitoring and management
Year: 2016
Clinical course and changes in high-resolution computed tomography findings in patients with idiopathic pulmonary fibrosis without honeycombing
Source: International Congress 2015 – New insights into IIPs
Year: 2015
Lung functions and imaging characteristics of the patients with combined pulmonary fibrosis and emphysema
Source: International Congress 2015 – IPF: clinical aspects
Year: 2015
Comparison of densitometric and visual scoring in the assessment of severity of idiopathic fibrotic interstitial pneumonias: Preliminary observations
Source: International Congress 2015 – New insights into IIPs
Year: 2015
Disease progression in IPF assessed using pulmonary function tests and functional respiratory imaging (FRI) – A pilot study
Source: International Congress 2014 – COPD and PAH related imaging
Year: 2014
Longitudinal monitoring of disease progression in children with mild CF using hyperpolarised gas MRI and LCI
Source: International Congress 2016 – The best is yet to come in terms of lung function
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept